Background: Because Traditional Chinese Medicine (TCM) preparations are often combinations of multiple herbs containing hundreds of compounds, they have been di cult to study. Compound Kushen Injection (CKI) is a complex mixture cancer treatment used in Chinese hospitals for over twenty years.
increase in the proportion of cells in G1 phase and decrease in S phase ( Fig. 1a and b) . Similarly, 121 in MDA-MB-231 cells, although a consistent increase in G1 phase was not observed, CKI caused a 122 decrease in S phase particularly at the 24-hour time point ( Fig. 1a and b) indicating possible 123 incidence of cell cycle arrest at G1 phase. Furthermore, at 2 mg/ml of total alkaloids, CKI 124 consistently induced significantly higher level of apoptosis in both cell lines at both time points transcriptomes from CKI treated MCF-7 cells [28] and have included those results for comparison 133 below. The samples from each cell line contained 7 groups at 3 time points ( Fig. 2a ), in triplicate 134 for every group. In the multidimensional scaling (MDS) analysis, each cell line clustered 135 independently and generally, within the cell line clusters, untreated cells clustered apart from 136 treated cells (Additional file 2: Fig. S1 ).
137
With the mapping rate were around 90% (Additional file 3: Table S2 ), a p-value based ranked 138 list of DE genes (compared to untreated from each time point) was generated for both cell lines 139 (Additional file 4: Table S3 , sheet 1-4). This list was used to select the shared DE genes. This 140 analysis generated thousands of DE genes (Additional file 4: Table S3 , sheet 5) across Hep G2 and 141 MDA-MB-231 cell lines.
142
Because for each cell line the respective treatment groups clustered together on the MDS plot, 143 there were large numbers of shared genes between them. As a result, we identified a set of 6852 Heatmap is split into four parts based on gene content and expression pattern: 5442 di↵erentially regulated genes with expression not shared between the two cell lines, 3157 upregulated genes shared between both cell lines, 3522 down-regulated genes shared between both cell lines, and 173 discordantly regulated genes with di↵erential expression shared between both cell lines.
Figure 3. Validation of gene expression and e↵ects of low dose CKI using RT-qPCR. A) Comparison of DE genes between RNA-seq results (left) and RT-qPCR validation (right) for each cell line at 2 time-points.
Three DE genes (CYP1A1, TP53 and CCND1) were chosen for validation. Gene expression was generally consistent between transcriptome data and qPCR data. B) Dose response of CKI using a subset of genes with conserved expression in Hep G2 (left), and MDA-MB-231 (right) from 0 mg/ml to 1 mg/ml of total alkaloids. Six genes (CYP1A1, TP53, CCND1, Rap2GAP1, E2F2 and PCNA) were selected based on their relevance to important pathways perturbed by CKI. RT-qPCR results are presented as expression relative to RPS13. Data are represented as mean ±SEM (n>3). A t-test was used to compare CKI doses with "untreated" (*p<0.05, **p<0.01, ***p<0.001, ****p<0.0001).
file 6: Table S4 , sheet 9-12). For both KEGG pathway and DO enrichment, the e↵ects of CKI on 189 both cell lines were similar.
190
In addition to cell line specific functional enrichment of DE genes, we also analyzed the 191 over-represented GO terms for shared DE genes (Fig. 5a ). The most significant clusters were 192 highly relevant to metabolic process, such as "cellular macromolecule metabolic process", as well as 193 the corresponding positive/negative regulatory biological process (Additional file 6: Table S4 , sheet 194 13). Moreover, various signaling pathways, though not forming a large cluster, were also significant, 195 for example, "regulation of signal transduction" and "intracellular receptor signaling pathway". expression patterns into these target pathways. Within the 21 pathways in cancer, the "cell cycle" 215 still featured prominently (Fig. 6a ). The expression of almost every gene in the cell cycle pathway 216 was a↵ected by CKI, with most of them suppressed. We did not observe this kind of overall pathway suppression in any of the other pathways. We have displayed the summaries for the In addition to the cell cycle pathway, there were 21 associated pathways in cancer that were perturbed by CKI. The e↵ects of CKI on both cell lines were similar, with changes in TARGET database genes indicated by arrows. Compared to other pathways in cancer, the e↵ects of CKI on the cell cycle pathway showed overall down-regulation.
understanding the mechanism of action of CKI on cancer cells. developmental processes contribute to tumorigenesis and metastasis [20, 36] . It is tempting to speculate that CKI may alter these functions in vivo, possibly altering angiogenesis which is 276 critical for tumors [9] . In addition, there were metabolic pathways and terms that were also 277 identified as perturbed by CKI. E↵ects on many targets/pathways is one of the expected features 278 of TCM drugs which likely hit multiple targets [7] . 279 We have examined the e↵ect of a complex mixture of plant natural products (CKI) on di↵erent components of CKI that have been linked to the regulation of 52 of our core genes (Fig. 7d ). We 288 can see from the network diagram in Fig. 7d that one to one, one to many and many to many 289 relationships exist between CKI components and genes which is consistent with previous studies 290 [38, 18, 46] . As more information becomes available for individual components, we will be able to 291 construct a more comprehensive model of CKI mechanism based on network analysis.
292

Conclusion 293
Our systematic analysis of gene expression changes in cancer cells caused by a complex herbal 294 extract used in TCM has proven to be e↵ective at identifying candidate molecular pathways. CKI 295 has consistent and specific e↵ects on gene expression across multiple cancer cell lines and it also 296 consistently induces apoptosis in vitro. These e↵ects show that CKI can suppress the expression of 297 cell cycle regulatory genes and other well characterized cancer related genes and pathways.
298
Validation of a subset of DE genes at lower doses of CKI has shown a dose-response relationship 299 that suggests that CKI may have similar e↵ects in vivo at clinically relevant concentrations. Our 300 results provide a molecular basis for further investigation of the mechanism of action of CKI. All RNA-seq data raw and processed data were deposited at the Gene Expression Omnibus 323 (GEO) data repository (XXXXXXX).
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